Cardiology Today Intervention

BETA - Tell us what you think about Healio

Cardiology

Welcome, Guest

Sign in for a personal experience.

Customized content served to meet your interests.

Login

All Specialties
Cardiology

Healio › Cardiology › News › Cardiology Today Intervention

Currently Viewing:

The following articles appeared in the print edition of CARDIOLOGY TODAY INTERVENTION.

March/April 2012

Cover Story
Controversy in the Cath Lab

5 Questions with Dr. Bhatt
A Conversation with Dean J. Kereiakes, MD

Business News
AngioDynamics to Purchase Navilyst Medical for $372 million

Sanofi-Aventis, Bristol-Myers Squibb Collect Damages in Clopidogrel Litigation

BridgePoint Medical, Covidien Reach Agreement on Peripheral Vascular Devices

C.R. Bard Acquires PTA Balloon Manufacturer

US Interventional Cardiology Market Forecast: Decline Expected Through 2016

Case Challenges
The Szabo Technique in a Patient with Ostial RCA In-Stent Restenosis
Amit Sharma, MD; Jason C. Kovacic, MD, PhD; Samin Sharma, MD

Clinical News
Assessment of Prasugrel in Randomized Trials Confirmed in 'Real World'

PROTECT Trial Highlights Improvements in Carotid Artery Stenting

New-Generation DES Outperformed Old in Swedish Registry

EVEREST II Substudy Affirms Feasibility, Efficacy of Percutaneous Mitral Leaflet Repair

Processing FAME II: Enrollment Halted After Positive Results Observed for OMT Plus FFR-guided PCI

Behavioral Intervention Found Critical in Patients Sustaining Physical Activity After PCI

DES May Be Preferable to BMS in Oldest Patients

Two Programs Launched to Examine Renal Denervation System

Cutting Edge
Optimizing Coronary Revascularization with Near-Infrared Spectroscopy
Joshua M. Stolker, MD

Feature
Deconstructing Longitudinal Stent Deformation

PAD in Focus
Drug-Coated Balloons and Stents for Endovascular Treatment of PAD
Subhash Banerjee, MD

Regulatory News
FDA-Approved DES for CAD is First to Feature Diabetes Indication

FDA, Device Industry Strike Deal on Review Process Fees

CMS proposes coverage plan for TAVR

AAA Stent Graft System Obtains CE Mark

ACS Indication Sought for Rivaroxaban

The Take Home
Concerns and Challenges Selecting Patients for MitraClip or TAVR
Peter C. Block, MD